These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
833 related articles for article (PubMed ID: 18376241)
21. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. Bazzigaluppi E; Lampasona V; Barera G; Venerando A; Bianchi C; Chiumello G; Bonifacio E; Bosi E J Autoimmun; 1999 Feb; 12(1):51-6. PubMed ID: 10028022 [TBL] [Abstract][Full Text] [Related]
22. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003 [TBL] [Abstract][Full Text] [Related]
23. Comparison of commercially available serologic kits for the detection of celiac disease. Naiyer AJ; Hernandez L; Ciaccio EJ; Papadakis K; Manavalan JS; Bhagat G; Green PH J Clin Gastroenterol; 2009 Mar; 43(3):225-32. PubMed ID: 18724250 [TBL] [Abstract][Full Text] [Related]
24. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613 [TBL] [Abstract][Full Text] [Related]
25. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody. Steinsbø Ø; Dørum S; Lundin KE; Sollid LM Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894 [TBL] [Abstract][Full Text] [Related]
26. Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase. Dahle C; Hagman A; Ignatova S; Ström M Aliment Pharmacol Ther; 2010 Jul; 32(2):254-60. PubMed ID: 20456302 [TBL] [Abstract][Full Text] [Related]
27. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease. Di Tola M; Marino M; Casale R; Di Battista V; Borghini R; Picarelli A Immunobiology; 2016 Jan; 221(1):63-9. PubMed ID: 26271834 [TBL] [Abstract][Full Text] [Related]
28. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children. Frulio G; Polimeno A; Palmieri D; Fumi M; Auricchio R; Piccolo E; Carandente Giarrusso P Clin Chim Acta; 2015 Jun; 446():237-40. PubMed ID: 25944768 [TBL] [Abstract][Full Text] [Related]
29. [Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase]. Piaggio MV; Demonte AM; Sihufe G; Garcilazo S; Esper MC; Wagener M; Aleanzi M Medicina (B Aires); 1999; 59(6):693-7. PubMed ID: 10752210 [TBL] [Abstract][Full Text] [Related]
30. Unexpected role of surface transglutaminase type II in celiac disease. Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Prince HE Clin Vaccine Immunol; 2006 Jan; 13(1):150-1. PubMed ID: 16426013 [TBL] [Abstract][Full Text] [Related]
32. Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease. Sárdy M; Csikós M; Geisen C; Preisz K; Kornseé Z; Tomsits E; Töx U; Hunzelmann N; Wieslander J; Kárpáti S; Paulsson M; Smyth N Clin Chim Acta; 2007 Feb; 376(1-2):126-35. PubMed ID: 16987503 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795 [TBL] [Abstract][Full Text] [Related]
34. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Sugai E; Nachman F; Váquez H; González A; Andrenacci P; Czech A; Niveloni S; Mazure R; Smecuol E; Cabanne A; Mauriño E; Bai JC Dig Liver Dis; 2010 May; 42(5):352-8. PubMed ID: 19679520 [TBL] [Abstract][Full Text] [Related]
36. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease. de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980 [TBL] [Abstract][Full Text] [Related]
37. [Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease]. Matusiewicz K; Iwańczak B; Matusiewicz M; Iwańczak F Pol Merkur Lekarski; 2006 Jan; 20(115):17-21. PubMed ID: 16617728 [TBL] [Abstract][Full Text] [Related]
38. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Leister F; Yang S; Krivogorsky B; Alaedini A; Yolken R Biol Psychiatry; 2010 Jul; 68(1):100-4. PubMed ID: 20471632 [TBL] [Abstract][Full Text] [Related]
39. Serologic markers of celiac disease in psoriatic patients. Damasiewicz-Bodzek A; Wielkoszyński T J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1055-61. PubMed ID: 18384553 [TBL] [Abstract][Full Text] [Related]
40. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Sblattero D; Berti I; Trevisiol C; Marzari R; Tommasini A; Bradbury A; Fasano A; Ventura A; Not T Am J Gastroenterol; 2000 May; 95(5):1253-7. PubMed ID: 10811336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]